shanghai zhangjiang hi-tech park development announced that the 9th Board of Directors' 4th meeting approved the proposal for its wholly-owned subsidiary, Shanghai Zhangjiang Haicheng Entrepreneurship Investment Co., Ltd., to transfer 3.9513% equity of Shanghai Simorro Biotechnology Co., Ltd. through public listing. The wholly-owned subsidiary plans to publicly list its 3.9513% equity in Shanghai Simorro Biotechnology through Shanghai United Property Exchange, with the listing price not lower than the evaluation price filed by Shanghai Pudong New Area State-owned Assets Supervision and Administration Commission.
张江高科：全资子公司拟公开挂牌转让上海赛默罗生物科技3.9513%股权
shanghai zhangjiang hi-tech park development: A wholly-owned subsidiary intends to publicly list and transfer 3.9513% equity of Shanghai Simorro Biotechnology.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated